Atlas Trials

Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

Clinical trial NCT01646489 · COMPLETED

Trial details

NCT number
NCT01646489
Sponsor
Santaris Pharma A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis CChronic Hepatitis C
Start date
2012-06-01
Primary completion
2012-09-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.